Clinical Trial Update: Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating methods to estimate and reduce cardiovascular risk in patients with schizophrenia using lipid measures and ischemic ele…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Northwestern University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: TERMINATED | Results posted: 2025-10-02